Odyssey Therapeutics, Inc. · NASDAQ:ODTX
Jeito II S.L.P. reported a 7.80% stake in Odyssey Therapeutics, Inc. (Schedule 13D)
Event May 8, 2026 · Filed May 15, 2026
Jeito II S.L.P. reported a 7.80% stake in Odyssey Therapeutics, Inc., 3,690,145 shares, with active intent on May 8, 2026. Filed May 15, 2026 (Schedule 13D).
- Stake
- 7.80%
- Shares
- 3,690,145
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Jeito II S.L.P. | 7.80% | 3,690,145 |
| Jeito Capital SAS | 7.80% | 3,690,145 |
| Rafaele Tordjman | 7.80% | 3,690,145 |
| Sabine Dandiguian | 7.80% | 3,690,145 |
Source
Related
- Odyssey Therapeutics, Inc.
- Jeito II S.L.P.
- Odyssey Therapeutics, Inc. shareholders
- Schedule 13G · FMR LLC · Jun 5, 2026
- Schedule 13D · SR One Capital Management, LLC · May 18, 2026
- Schedule 13D · Tpg Gp A, LLC · May 18, 2026
- Schedule 13G · Lightspeed Venture Partners XV-B (Ignite), L.P. · May 18, 2026
- Schedule 13D · Dimension Capital II, L.P. · May 15, 2026